Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy. (Q36028083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

A M Nordentoft

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

S Cold

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

N T Clausen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

N I Nissen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

English

0 references

publication date

1 May 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

535-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years

22 September 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Report of the Committee on Hodgkin's Disease Staging Classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Hodgkin's disease, stages I and II.Relationship of recurrence to size of disease, radiation dose, and number of sites involved

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Bulky mediastinal Hodgkin's disease management and prognosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

The pathology and nomenclature of Hodgkin's disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001736

Prognostic significance of tumour burden in Hodgkin's disease PS I and II

23 September 2018

1 reference

12 December 2020

Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy

1 reference

12 December 2020

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

1 reference

12 December 2020

Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease

1 reference

12 December 2020

Prognostic significance of mediastinal mass in adult Hodgkin's disease

1 reference

12 December 2020

Prognostic factors in Hodgkin's disease with special reference to age

1 reference

12 December 2020

Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1987.109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3300762%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

3300762

1 reference